|
Name |
Anthracobic acid B
|
| Molecular Formula | C25H32O4 | |
| IUPAC Name* |
(2E,4E,6Z,8E)-9-[(1aS,2S,3aR,7aR,7bS)-2-[(E)-but-2-en-2-yl]-2-hydroxy-6-methyl-3,3a,4,7,7a,7b-hexahydro-1aH-naphtho[1,2-b]oxiren-3-yl]-6-methylnona-2,4,6,8-tetraenoic acid
|
|
| SMILES |
C/C=C(\C)/[C@@]1([C@@H]2[C@@H](O2)[C@@H]3CC(=CC[C@H]3C1/C=C/C=C(/C)\C=C\C=C\C(=O)O)C)O
|
|
| InChI |
InChI=1S/C25H32O4/c1-5-18(4)25(28)21(11-8-10-16(2)9-6-7-12-22(26)27)19-14-13-17(3)15-20(19)23-24(25)29-23/h5-13,19-21,23-24,28H,14-15H2,1-4H3,(H,26,27)/b9-6+,11-8+,12-7+,16-10-,18-5+/t19-,20-,21?,23+,24+,25-/m1/s1
|
|
| InChIKey |
RFLQWGOTYZWRJB-WSWMBLLHSA-N
|
|
| Synonyms |
Anthracobic acid B
|
|
| CAS | NA | |
| PubChem CID | 139588835 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 396.5 | ALogp: | 4.6 |
| HBD: | 2 | HBA: | 4 |
| Rotatable Bonds: | 6 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 70.1 | Aromatic Rings: | 3 |
| Heavy Atoms: | 29 | QED Weighted: | 0.281 |
| Caco-2 Permeability: | -4.778 | MDCK Permeability: | 0.00000880 |
| Pgp-inhibitor: | 0 | Pgp-substrate: | 0.001 |
| Human Intestinal Absorption (HIA): | 0.026 | 20% Bioavailability (F20%): | 0.059 |
| 30% Bioavailability (F30%): | 0.344 |
| Blood-Brain-Barrier Penetration (BBB): | 0.23 | Plasma Protein Binding (PPB): | 92.46% |
| Volume Distribution (VD): | 0.441 | Fu: | 8.98% |
| CYP1A2-inhibitor: | 0.441 | CYP1A2-substrate: | 0.12 |
| CYP2C19-inhibitor: | 0.183 | CYP2C19-substrate: | 0.108 |
| CYP2C9-inhibitor: | 0.53 | CYP2C9-substrate: | 0.981 |
| CYP2D6-inhibitor: | 0.825 | CYP2D6-substrate: | 0.864 |
| CYP3A4-inhibitor: | 0.672 | CYP3A4-substrate: | 0.127 |
| Clearance (CL): | 1.488 | Half-life (T1/2): | 0.094 |
| hERG Blockers: | 0.009 | Human Hepatotoxicity (H-HT): | 0.962 |
| Drug-inuced Liver Injury (DILI): | 0.958 | AMES Toxicity: | 0.261 |
| Rat Oral Acute Toxicity: | 0.601 | Maximum Recommended Daily Dose: | 0.949 |
| Skin Sensitization: | 0.737 | Carcinogencity: | 0.464 |
| Eye Corrosion: | 0.019 | Eye Irritation: | 0.045 |
| Respiratory Toxicity: | 0.964 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC003585 | ![]() |
1.000 | D0G3PI | ![]() |
0.311 | ||
| ENC002015 | ![]() |
0.343 | D00DKK | ![]() |
0.311 | ||
| ENC001936 | ![]() |
0.314 | D02DGU | ![]() |
0.311 | ||
| ENC005165 | ![]() |
0.314 | D0FG6M | ![]() |
0.295 | ||
| ENC005164 | ![]() |
0.314 | D05QDC | ![]() |
0.274 | ||
| ENC002157 | ![]() |
0.301 | D0S7WX | ![]() |
0.257 | ||
| ENC003852 | ![]() |
0.300 | D0B1IP | ![]() |
0.230 | ||
| ENC004753 | ![]() |
0.280 | D0MY8N | ![]() |
0.203 | ||
| ENC003854 | ![]() |
0.279 | D0B4RU | ![]() |
0.190 | ||
| ENC003853 | ![]() |
0.279 | D0E9KA | ![]() |
0.182 | ||